MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-06-0008447
Sreeven Pharma Private Limited
Sreeven Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.92 Cr
▲ 284% YoY
Net loss · FY 2025
₹3.15 Cr
Net margin -164.6%
EBITDA · FY 2025
-₹2.45 Cr
EBITDA margin -127.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.69 Cr
Issued & subscribed
Open charges
₹6 Cr
Satisfied ₹9.06 Cr
Company age
34 yrs
Est. 1992
Directors on board
2
As per MCA filings
About Sreeven Pharma Private Limited
Data last updated:
Sreeven Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U65993TG1992PTC014481. Its GSTIN is 29AAICS9525P1ZD (Karnataka).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.69 Cr. It was formerly known as Richie Investments & Consultants Pvt Ltd. It is led by directors Devendrappa Jegashetty (Managing Director) and Sandeep Gokaraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.92 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.15 Cr (net margin -164.6%) and EBITDA of -₹2.45 Cr (EBITDA margin -127.8%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹9.06 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company.
Sreeven Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-06-0008447). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U65993TG1992PTC014481
Registration Number 014481
Incorporation Date 08 July 1992
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-06-0008447
CIN history
Sreeven Pharma has one previous CIN (Corporate Identification Number): U65993AP1992PTC014481. The current CIN is U65993TG1992PTC014481, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U65993TG1992PTC014481 | Current |
| U65993AP1992PTC014481 | Previous |
Recognitions & Rankings of Sreeven Pharma
Contact details
Sreeven Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sreeven Pharma Private Limited, buy the company report.
Comprehensive company report
Sreeven Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sreeven Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sreeven Pharma Private Limited, buy the company report.
Financials of Sreeven Pharma Private Limited
FY 2025 filings availableSreeven Pharma Private Limited reported revenue of ₹1.92 Cr (up 284% YoY) for FY 2025.
Revenue · FY 2025
₹1.92 Cr ▲ 284%
Net loss · FY 2025
₹3.15 Cr margin -164.6%
EBITDA · FY 2025
-₹2.45 Cr margin -127.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 284%
3 years · compounded
▼ 24%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 76%
3 years · compounded
▼ 103%
5 years · compounded
▼ 83%
Revenue rose 284% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.45 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.15 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -127.8% | ||||
| Net Profit Margin | -164.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sreeven Pharma Private Limited, buy the company report.
Board of directors of Sreeven Pharma Private Limited
Sreeven Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Gokaraju Also directs: Tyche Industries Limited, Sirona Life Sciences Private Limited | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
| Devendrappa Jegashetty | Managing Director | 11 Apr 2003 | 23 Years 6 Months | Current |
Auditor
Sreeven Pharma Private Limited is audited by Meenavali & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Meenavali & Associates | FY 2023 | 012208S |
Shareholding
The shareholding of Sreeven Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sreeven Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6 Cr
Satisfied charges
₹9.06 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2024 | 100972431 | Axis Bank Limited | ₹6 Cr | Open | |
| 27 Jan 2017 | 100083574 | Syndicate Bank | ₹1.2 Cr | Satisfied | |
| 22 Feb 2016 | 10627736 | Canara Bank | ₹4.95 Cr | Satisfied | |
| 26 Aug 2011 | 10312020 | Axis Bank Limited | ₹2.21 Cr | Satisfied | |
| 31 Oct 2008 | 10133241 | Syndicate Bank | ₹70 Lakh | Satisfied |
To see the full charge records of Sreeven Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Sreeven Pharma Private Limited has 2 court cases on record: 2 filed by Sreeven Pharma. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against The State of Karnataka and Ors | Disposed |
To see the full case history of Sreeven Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sreeven Pharma Private Limited has 5 MSME Form 1 returns on record between 2023 and 2024, listing 48 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mallikarjuna Pharma | |||
| Dhanasri Enterprises | |||
| an individual supplier | |||
| an individual supplier | |||
| LCGC Chrom Consumables LLP |
To see the full MSME payment records of Sreeven Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Sreeven Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICS9525P1ZD | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sreeven Pharma Private Limited, buy the company report.
Recent activity
Sreeven Pharma Private Limited has 8 board changes on record since 2003: 2 appointments and 6 cessations. The latest: Jegashette Vijaya Laxmi ceased to be Director on 22 Apr 2024.
AGM
Sreeven Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sreeven Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 6.00 Cr with Charge ID 100972431 was registered on 19 Aug 2024.
Ceased
Jegashette Vijaya Laxmi ceased to be Director.
Ceased
Suryakanth Patil ceased to be Director.
Charges
A charge registered on 27 Jan 2017 via Charge ID 100083574 with Syndicate Bank was fully satisfied on 10 Oct 2022.
Charges
A charge registered on 22 Feb 2016 via Charge ID 10627736 with Canara Bank was fully satisfied on 10 Oct 2022.
Ceased
Sandeep Gokaraju ceased to be Additional Director.
Appointed
Sandeep Gokaraju was appointed as Director.
Charges
A charge with Canara Bank of Rs. 4.95 Cr registered on 22 Feb 2016 with Charge ID 10627736 was modified on 09 Jul 2020.
Charges
A charge with Syndicate Bank amounted to Rs. 1.20 Cr with Charge ID 100083574 was registered on 27 Jan 2017.
Charges
A charge with Canara Bank amounted to Rs. 4.95 Cr with Charge ID 10627736 was registered on 22 Feb 2016.
10 earlier events are in the company report.
Frequently asked questions
Sreeven Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 1992 (34+ years old) and is registered under CIN U65993TG1992PTC014481.
Sreeven Pharma has 2 current directors:
- Devendrappa Jegashetty - Managing Director
- Sandeep Gokaraju - Director
The latest financial statements of Sreeven Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sreeven Pharma is 29AAICS9525P1ZD, registered in Karnataka.
The CIN (Corporate Identification Number) of Sreeven Pharma is U65993TG1992PTC014481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sreeven Pharma has 2 court cases on record: 2 filed by the company.
Sreeven Pharma was incorporated on 08 July 1992, making it 34+ years old. It is registered with the Registrar of Companies, Hyderabad.
Jegashette Vijaya Laxmi ceased to be Director on 22 Apr 2024. Suryakanth Patil ceased to be Director on 22 Apr 2024. Sandeep Gokaraju ceased to be Additional Director on 30 Sep 2022. Sreeven Pharma has 8 board changes on record in total.
Yes, Sreeven Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-06-0008447).
Sreeven Pharma has 5 MSME Form 1 returns on record between 2023 and 2024, listing 48 overdue payments to 14 micro and small suppliers. The latest return was filed on 27 Apr 2024.
The registered office of Sreeven Pharma is at H.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074.